← Study Library
RCT · 2016 · n=38
Promisingcounts toward this tierThe effect of pomegranate juice on clinical signs, matrix metalloproteinases and antioxidant status in patients with knee osteoarthritis
Ghoochani N, Karandish M, Mowla K, Haghighizadeh MH, Jalali MT · Journal of the Science of Food and Agriculture
Promisingcounts toward this tier
The only randomized trial of pomegranate as a food rather than an extract. WOMAC total, stiffness and physical-function scores all fell within the juice group (p = 0.01, p < 0.001, p = 0.01). Two measures were reported against the control group and both separated: serum MMP-13, an enzyme that cuts type II collagen, fell (p = 0.02) and glutathione peroxidase rose (p = 0.02).
- Population
- Adults with knee osteoarthritis, single centre in Ahvaz, Iran
- Intervention
- Pomegranate juice for 6 weeks
- Comparator
- Control group, no placebo beverage
- Limitations
- n=38, six weeks, one centre, and there was no placebo beverage — the control group drank nothing, so neither participants nor the symptom scores are blinded. The WOMAC results are reported as within-group change; the between-group comparisons that are stated are for the biochemistry, not the pain.
Cited by
1 entry references this study
- PomegranatePROM.
Foods & Nutrition → Foods with joint trials · key study